A群链球菌疫苗的分阶段临床开发与证据生成框架
A staged clinical development and evidence-generation framework for Group A Streptococcus vaccines
国际疫苗研究所团队在npj Vaccines发表观点文章,提出针对A群链球菌疫苗的平台无关分阶段临床开发与证据生成框架。该框架建议以实验室确诊的有症状咽峡炎作为初始许可的关键效力终点,并通过互补的效力、效果和实施研究在不同人群和结局中生成证据,以平衡试验可行性与公共卫生优先事项。
- Perspective
- Open access
- Published: 11 October 2026
npj Vaccines (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Group A Streptococcus (Strep A) causes substantial global morbidity and mortality, yet vaccine development faces scientific, regulatory, and strategic challenges. We propose a platform-agnostic, staged clinical development and evidence-generation framework aligning trial feasibility with public health priorities. Laboratory-confirmed symptomatic pharyngitis could provide a feasible pivotal efficacy endpoint for initial licensure, subject to regulatory agreement. Complementary efficacy, effectiveness, and implementation studies could then generate evidence across diverse populations and outcomes.
Acknowledgements
Thanks to Jean-Louis Excler and to numerous contributors at the Australian Strep A Vaccine Initiative (ASAVI), the International Vaccine Institute (IVI), and the Strep A Vaccine Global Consortium (SAVAC), for their thoughts and input.
Funding
This work was funded by the International Vaccine Institute Europe Regional Office through investment from the Swedish Ministry for Foreign Affairs grant UD2022/000123.
Author information
Author notes
These authors contributed equally: Alma Fulurija, Jerome H. Kim.
Authors and Affiliations
International Vaccine Institute, Europe Regional Office, Solna, Sweden
Alberto Cagigi, Annette Kraus & T. Anh Wartel
Murdoch Children’s Research Institute, Melbourne, Australia
Andrew Steer
The Kids Research Institute Australia, University of Western Australia, Perth, Australia
Jonathan Carapetis & Alma Fulurija
International Vaccine Institute, Seoul, Republic of Korea
Jerome H. Kim
College of Natural Sciences, Seoul National University, Seoul, Republic of Korea
Jerome H. Kim
Authors
- Alberto Cagigi
- Annette Kraus
- T. Anh Wartel
- Andrew Steer
- Jonathan Carapetis
- Alma Fulurija
- Jerome H. Kim
Corresponding author
Correspondence to Alberto Cagigi.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Cagigi, A., Kraus, A., Wartel, T.A. et al. A staged clinical development and evidence-generation framework for Group A Streptococcus vaccines. npj Vaccines (2026). https://doi.org/10.1038/s41541-026-01607-5
Received: 28 August 2026
Accepted: 01 October 2026
Published: 11 October 2026
DOI: https://doi.org/10.1038/s41541-026-01607-5
来源:Nature 健康护理主题 · nature.com